CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 102  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0711
LYS 10.0213
GLU 20.0393
LEU 30.0711
ARG 40.0390
CYS 50.0171
GLN 60.0568
CYS 70.0241
ILE 80.0239
LYS 90.0116
THR 100.0207
TYR 110.0172
SER 120.0173
LYS 130.0315
PRO 140.0241
PHE 150.0149
HIS 160.0162
PRO 170.0060
LYS 180.0225
PHE 190.0084
ILE 200.0083
LYS 210.0091
GLU 220.0143
LEU 230.0209
ARG 240.0442
VAL 250.0285
ILE 260.0222
GLU 270.0198
SER 280.0407
GLY 290.0361
PRO 300.0335
HIS 310.0219
CYS 320.0053
ALA 330.0281
ASN 340.0222
THR 350.0158
GLU 360.0199
ILE 370.0083
ILE 380.0085
VAL 390.0031
LYS 400.0076
LEU 410.0109
SER 420.0221
ASP 430.0167
GLY 440.0304
ARG 450.0187
GLU 460.0115
LEU 470.0117
CYS 480.0072
LEU 490.0103
ASP 500.0197
PRO 510.0296
LYS 520.0483
GLU 530.0249
ASN 540.0286
TRP 550.0199
VAL 560.0080
GLN 570.0119
ARG 580.0171
VAL 590.0202
VAL 600.0143
GLU 610.0151
LYS 620.0122
PHE 630.0031
LEU 640.0061
LYS 650.0108
ARG 660.0046
ALA 670.0272
GLU 680.0074
ASN 690.0141

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.